ABBREVIATIONS: HBOC(s) 5 hemoglobin-based oxygen carrier(s); HR(s) 5 hazard ratio(s). From the

ARBC transfusion in anaemic patients is clinically beneficial and cost-effective.

No abstract

No abstract

The aim of this retrospective cohort study was to identify early risk factors of mortality and develop a mortality risk stratification instrument for severely anaemic Jehovah's Witness patients. It has been shown that Jehovah's Witness patients with the Auckland Anaemia Mortality Risk Score (Auckland AMRS) of 0 to 3 had 4% mortality, Auckland AMRS 4 to 5 32%, Auckland AMRS 6 to 7 50% and Auckland AMRS 8 and above 83%. It is concluded that the Auckland AMRS predicts mortality of severely anaemic Jehovah's Witness patients.